APO Research
Talk to an analyst

APO RESEARCH · REPORT

Isoniazid Tablets

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Isoniazid Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

28 December 2025198 pages

Choose your research edition.

Industry ResearchIsoniazid Tablets Industry Research Report 2026145 pages · $2,950 USDIndustry Growth & TrendsGlobal Isoniazid Tablets Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Isoniazid Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Isoniazid Tablets Market Outlook and Growth Opportunities 2026214 pages · $4,250 USDMarket Analysis & ForecastGlobal Isoniazid Tablets Market Analysis and Forecast 2026-2032211 pages · $4,950 USD

Market perspective

The global Isoniazid Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Isoniazid Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Isoniazid Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Isoniazid Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Isoniazid Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Isoniazid Tablets include Yunpeng Pharmaceutical Group Co., Ltd., Tonghua Baishan Pharmaceutical Co., Ltd., Tiansheng Pharmaceutical Group Co., Ltd., Sichuan Deyuan Pharmaceutical Group Co., Ltd., Sancai Shiqi Pharmaceutical Co., Ltd., Jiangxi Haiersi Pharmaceutical Co., Ltd., Jichuang Pharmaceutical Group Co., Ltd., Hunan Xinhui Pharmaceutical Co., Ltd. and Hunan Shentaichun Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Isoniazid Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Isoniazid Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Isoniazid Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Isoniazid Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Isoniazid Tablets Segment by Company

Yunpeng Pharmaceutical Group Co., Ltd.

Tonghua Baishan Pharmaceutical Co., Ltd.

Tiansheng Pharmaceutical Group Co., Ltd.

Sichuan Deyuan Pharmaceutical Group Co., Ltd.

Sancai Shiqi Pharmaceutical Co., Ltd.

Jiangxi Haiersi Pharmaceutical Co., Ltd.

Jichuang Pharmaceutical Group Co., Ltd.

Hunan Xinhui Pharmaceutical Co., Ltd.

Hunan Shentaichun Pharmaceutical Co., Ltd.

Hunan Kangerjia Pharmaceutical Co., Ltd.

Hunan Hansen Pharmaceutical Co., Ltd.

Hunan Erkang Pharmaceutical Co., Ltd.

Hubei Renyue Pharmaceutical Co., Ltd.

Hubei Hendi Pharmaceutical Co., Ltd.

Hebei Changtian Pharmaceutical Co., Ltd.

Hebei Tiancheng Pharmaceutical Co., Ltd.

Hangzhou Minsheng Pharmaceutical Co., Ltd.

Harbin Pharmaceutical Group Pharmaceutical Factory

Sinopharm Guorui Pharmaceutical Co., Ltd.

Guilin Nanyao Co., Ltd.

Guangdong Xinfeng Pharmaceutical Co., Ltd.

Isoniazid Tablets Segment by Type

50mg

100mg

Isoniazid Tablets Segment by Application

Hospital

Clinic

Other

Isoniazid Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Isoniazid Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Isoniazid Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Isoniazid Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Isoniazid Tablets market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Isoniazid Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Isoniazid Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Isoniazid Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Isoniazid Tablets Industry Trends Table 2. Isoniazid Tablets Industry Drivers Table 3. Isoniazid Tablets Industry Opportunities and Challenges Table 4. Isoniazid Tablets Industry Restraints Table 5. Global Isoniazid Tablets Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Isoniazid Tablets Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Isoniazid Tablets Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Isoniazid Tablets Sales Market Share by Manufacturers Table 9. Global Isoniazid Tablets Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Isoniazid Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Isoniazid Tablets Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Isoniazid Tablets Manufacturers, Product Type & Application Table 13. Global Isoniazid Tablets Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Isoniazid Tablets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 50mg Table 17. Major Manufacturers of 100mg Table 18. Global Isoniazid Tablets Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Isoniazid Tablets Sales by Type (2021-2026) & (K Units) Table 20. Global Isoniazid Tablets Sales by Type (2027-2032) & (K Units) Table 21. Global Isoniazid Tablets Sales Market Share by Type (2021-2026) Table 22. Global Isoniazid Tablets Sales Market Share by Type (2027-2032) Table 23. Global Isoniazid Tablets Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Isoniazid Tablets Revenue by Type (2021-2026) & (K Units) Table 25. Global Isoniazid Tablets Revenue by Type (2027-2032) & (K Units) Table 26. Global Isoniazid Tablets Revenue Market Share by Type (2021-2026) Table 27. Global Isoniazid Tablets Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Clinic Table 30. Major Manufacturers of Other Table 31. Global Isoniazid Tablets Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Isoniazid Tablets Sales by Application (2021-2026) & (K Units) Table 33. Global Isoniazid Tablets Sales by Application (2027-2032) & (K Units) Table 34. Global Isoniazid Tablets Sales Market Share by Application (2021-2026) Table 35. Global Isoniazid Tablets Sales Market Share by Application (2027-2032) Table 36. Global Isoniazid Tablets Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Isoniazid Tablets Revenue by Application (2021-2026) & (K Units) Table 38. Global Isoniazid Tablets Revenue by Application (2027-2032) & (K Units) Table 39. Global Isoniazid Tablets Revenue Market Share by Application (2021-2026) Table 40. Global Isoniazid Tablets Revenue Market Share by Application (2027-2032) Table 41. Global Isoniazid Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Isoniazid Tablets Sales by Region (2021-2026) & (K Units) Table 43. Global Isoniazid Tablets Sales Market Share by Region (2021-2026) Table 44. Global Isoniazid Tablets Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Isoniazid Tablets Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Isoniazid Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Isoniazid Tablets Sales by Country (2021-2026) & (K Units) Table 48. North America Isoniazid Tablets Sales by Country (2027-2032) & (K Units) Table 49. Europe Isoniazid Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Isoniazid Tablets Sales by Country (2021-2026) & (K Units) Table 51. Europe Isoniazid Tablets Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Isoniazid Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Isoniazid Tablets Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Isoniazid Tablets Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Isoniazid Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Isoniazid Tablets Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Isoniazid Tablets Sales by Country (2027-2032) & (K Units) Table 58. Global Isoniazid Tablets Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Isoniazid Tablets Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Isoniazid Tablets Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Isoniazid Tablets Revenue Market Share by Region (2021-2026) Table 62. Global Isoniazid Tablets Revenue Market Share by Region (2027-2032) Table 63. Yunpeng Pharmaceutical Group Co., Ltd. Company Information Table 64. Yunpeng Pharmaceutical Group Co., Ltd. Business Overview Table 65. Yunpeng Pharmaceutical Group Co., Ltd. Isoniazid Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Yunpeng Pharmaceutical Group Co., Ltd. Isoniazid Tablets Product Portfolio Table 67. Yunpeng Pharmaceutical Group Co., Ltd. Recent Development Table 68. Tonghua Baishan Pharmaceutical Co., Ltd. Company Information Table 69. Tonghua Baishan Pharmaceutical Co., Ltd. Business Overview Table 70. Tonghua Baishan Pharmaceutical Co., Ltd. Isoniazid Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Tonghua Baishan Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio Table 72. Tonghua Baishan Pharmaceutical Co., Ltd. Recent Development Table 73. Tiansheng Pharmaceutical Group Co., Ltd. Company Information Table 74. Tiansheng Pharmaceutical Group Co., Ltd. Business Overview Table 75. Tiansheng Pharmaceutical Group Co., Ltd. Isoniazid Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Tiansheng Pharmaceutical Group Co., Ltd. Isoniazid Tablets Product Portfolio Table 77. Tiansheng Pharmaceutical Group Co., Ltd. Recent Development Table 78. Sichuan Deyuan Pharmaceutical Group Co., Ltd. Company Information Table 79. Sichuan Deyuan Pharmaceutical Group Co., Ltd. Business Overview Table 80. Sichuan Deyuan Pharmaceutical Group Co., Ltd. Isoniazid Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Sichuan Deyuan Pharmaceutical Group Co., Ltd. Isoniazid Tablets Product Portfolio Table 82. Sichuan Deyuan Pharmaceutical Group Co., Ltd. Recent Development Table 83. Sancai Shiqi Pharmaceutical Co., Ltd. Company Information Table 84. Sancai Shiqi Pharmaceutical Co., Ltd. Business Overview Table 85. Sancai Shiqi Pharmaceutical Co., Ltd. Isoniazid Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Sancai Shiqi Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio Table 87. Sancai Shiqi Pharmaceutical Co., Ltd. Recent Development Table 88. Jiangxi Haiersi Pharmaceutical Co., Ltd. Company Information Table 89. Jiangxi Haiersi Pharmaceutical Co., Ltd. Business Overview Table 90. Jiangxi Haiersi Pharmaceutical Co., Ltd. Isoniazid Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Jiangxi Haiersi Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio Table 92. Jiangxi Haiersi Pharmaceutical Co., Ltd. Recent Development Table 93. Jichuang Pharmaceutical Group Co., Ltd. Company Information Table 94. Jichuang Pharmaceutical Group Co., Ltd. Business Overview Table 95. Jichuang Pharmaceutical Group Co., Ltd. Isoniazid Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Jichuang Pharmaceutical Group Co., Ltd. Isoniazid Tablets Product Portfolio Table 97. Jichuang Pharmaceutical Group Co., Ltd. Recent Development Table 98. Hunan Xinhui Pharmaceutical Co., Ltd. Company Information Table 99. Hunan Xinhui Pharmaceutical Co., Ltd. Business Overview Table 100. Hunan Xinhui Pharmaceutical Co., Ltd. Isoniazid Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Hunan Xinhui Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio Table 102. Hunan Xinhui Pharmaceutical Co., Ltd. Recent Development Table 103. Hunan Shentaichun Pharmaceutical Co., Ltd. Company Information Table 104. Hunan Shentaichun Pharmaceutical Co., Ltd. Business Overview Table 105. Hunan Shentaichun Pharmaceutical Co., Ltd. Isoniazid Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Hunan Shentaichun Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio Table 107. Hunan Shentaichun Pharmaceutical Co., Ltd. Recent Development Table 108. Hunan Kangerjia Pharmaceutical Co., Ltd. Company Information Table 109. Hunan Kangerjia Pharmaceutical Co., Ltd. Business Overview Table 110. Hunan Kangerjia Pharmaceutical Co., Ltd. Isoniazid Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Hunan Kangerjia Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio Table 112. Hunan Kangerjia Pharmaceutical Co., Ltd. Recent Development Table 113. Hunan Hansen Pharmaceutical Co., Ltd. Company Information Table 114. Hunan Hansen Pharmaceutical Co., Ltd. Business Overview Table 115. Hunan Hansen Pharmaceutical Co., Ltd. Isoniazid Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Hunan Hansen Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio Table 117. Hunan Hansen Pharmaceutical Co., Ltd. Recent Development Table 118. Hunan Erkang Pharmaceutical Co., Ltd. Company Information Table 119. Hunan Erkang Pharmaceutical Co., Ltd. Business Overview Table 120. Hunan Erkang Pharmaceutical Co., Ltd. Isoniazid Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Hunan Erkang Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio Table 122. Hunan Erkang Pharmaceutical Co., Ltd. Recent Development Table 123. Hubei Renyue Pharmaceutical Co., Ltd. Company Information Table 124. Hubei Renyue Pharmaceutical Co., Ltd. Business Overview Table 125. Hubei Renyue Pharmaceutical Co., Ltd. Isoniazid Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Hubei Renyue Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio Table 127. Hubei Renyue Pharmaceutical Co., Ltd. Recent Development Table 128. Hubei Hendi Pharmaceutical Co., Ltd. Company Information Table 129. Hubei Hendi Pharmaceutical Co., Ltd. Business Overview Table 130. Hubei Hendi Pharmaceutical Co., Ltd. Isoniazid Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Hubei Hendi Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio Table 132. Hubei Hendi Pharmaceutical Co., Ltd. Recent Development Table 133. Hebei Changtian Pharmaceutical Co., Ltd. Company Information Table 134. Hebei Changtian Pharmaceutical Co., Ltd. Business Overview Table 135. Hebei Changtian Pharmaceutical Co., Ltd. Isoniazid Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Hebei Changtian Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio Table 137. Hebei Changtian Pharmaceutical Co., Ltd. Recent Development Table 138. Hebei Tiancheng Pharmaceutical Co., Ltd. Company Information Table 139. Hebei Tiancheng Pharmaceutical Co., Ltd. Business Overview Table 140. Hebei Tiancheng Pharmaceutical Co., Ltd. Isoniazid Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. Hebei Tiancheng Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio Table 142. Hebei Tiancheng Pharmaceutical Co., Ltd. Recent Development Table 143. Hangzhou Minsheng Pharmaceutical Co., Ltd. Company Information Table 144. Hangzhou Minsheng Pharmaceutical Co., Ltd. Business Overview Table 145. Hangzhou Minsheng Pharmaceutical Co., Ltd. Isoniazid Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 146. Hangzhou Minsheng Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio Table 147. Hangzhou Minsheng Pharmaceutical Co., Ltd. Recent Development Table 148. Harbin Pharmaceutical Group Pharmaceutical Factory Company Information Table 149. Harbin Pharmaceutical Group Pharmaceutical Factory Business Overview Table 150. Harbin Pharmaceutical Group Pharmaceutical Factory Isoniazid Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 151. Harbin Pharmaceutical Group Pharmaceutical Factory Isoniazid Tablets Product Portfolio Table 152. Harbin Pharmaceutical Group Pharmaceutical Factory Recent Development Table 153. Sinopharm Guorui Pharmaceutical Co., Ltd. Company Information Table 154. Sinopharm Guorui Pharmaceutical Co., Ltd. Business Overview Table 155. Sinopharm Guorui Pharmaceutical Co., Ltd. Isoniazid Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 156. Sinopharm Guorui Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio Table 157. Sinopharm Guorui Pharmaceutical Co., Ltd. Recent Development Table 158. Guilin Nanyao Co., Ltd. Company Information Table 159. Guilin Nanyao Co., Ltd. Business Overview Table 160. Guilin Nanyao Co., Ltd. Isoniazid Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 161. Guilin Nanyao Co., Ltd. Isoniazid Tablets Product Portfolio Table 162. Guilin Nanyao Co., Ltd. Recent Development Table 163. Guangdong Xinfeng Pharmaceutical Co., Ltd. Company Information Table 164. Guangdong Xinfeng Pharmaceutical Co., Ltd. Business Overview Table 165. Guangdong Xinfeng Pharmaceutical Co., Ltd. Isoniazid Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 166. Guangdong Xinfeng Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio Table 167. Guangdong Xinfeng Pharmaceutical Co., Ltd. Recent Development Table 168. Key Raw Materials Table 169. Raw Materials Key Suppliers Table 170. Isoniazid Tablets Distributors List Table 171. Isoniazid Tablets Customers List Table 172. Research Programs/Design for This Report Table 173. Authors List of This Report Table 174. Secondary Sources Table 175. Primary Sources List of Figures Figure 1. Isoniazid Tablets Product Image Figure 2. Global Isoniazid Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Isoniazid Tablets Market Size (2021-2032) & (US$ Million) Figure 4. Global Isoniazid Tablets Sales (2021-2032) & (K Units) Figure 5. Global Isoniazid Tablets Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Isoniazid Tablets Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 50mg Image Figure 9. 100mg Image Figure 10. Global Isoniazid Tablets Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Isoniazid Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Isoniazid Tablets Sales Market Share by Type (2021-2032) Figure 13. Global Isoniazid Tablets Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Isoniazid Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Isoniazid Tablets Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Clinic Image Figure 18. Other Image Figure 19. Global Isoniazid Tablets Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Isoniazid Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Isoniazid Tablets Sales Market Share by Application (2021-2032) Figure 22. Global Isoniazid Tablets Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Isoniazid Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Isoniazid Tablets Revenue Market Share by Application (2021-2032) Figure 25. North America Isoniazid Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Isoniazid Tablets Sales Market Share by Country (2021-2032) Figure 27. U.S. Isoniazid Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Isoniazid Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Isoniazid Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Isoniazid Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Isoniazid Tablets Sales Market Share by Country (2021-2032) Figure 32. Germany Isoniazid Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Isoniazid Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Isoniazid Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Isoniazid Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Isoniazid Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Isoniazid Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Isoniazid Tablets Sales Market Share by Country (2021-2032) Figure 39. China Isoniazid Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Isoniazid Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Isoniazid Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Isoniazid Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Isoniazid Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Isoniazid Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Isoniazid Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Isoniazid Tablets Sales Market Share by Country (2021-2032) Figure 47. Brazil Isoniazid Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Isoniazid Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Isoniazid Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Isoniazid Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Isoniazid Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Isoniazid Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Isoniazid Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Isoniazid Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Isoniazid Tablets Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Isoniazid Tablets Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Isoniazid Tablets Revenue (2021-2032) & (US$ Million) Figure 58. North America Isoniazid Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Isoniazid Tablets Revenue (2021-2032) & (US$ Million) Figure 60. Europe Isoniazid Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Isoniazid Tablets Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Isoniazid Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Isoniazid Tablets Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Isoniazid Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Isoniazid Tablets Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Isoniazid Tablets Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • 50mg
  • 100mg
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Yunpeng Pharmaceutical Group Co., Ltd.
  • Tonghua Baishan Pharmaceutical Co., Ltd.
  • Tiansheng Pharmaceutical Group Co., Ltd.
  • Sichuan Deyuan Pharmaceutical Group Co., Ltd.
  • Sancai Shiqi Pharmaceutical Co., Ltd.
  • Jiangxi Haiersi Pharmaceutical Co., Ltd.
  • Jichuang Pharmaceutical Group Co., Ltd.
  • Hunan Xinhui Pharmaceutical Co., Ltd.
  • Hunan Shentaichun Pharmaceutical Co., Ltd.
  • Hunan Kangerjia Pharmaceutical Co., Ltd.
  • Hunan Hansen Pharmaceutical Co., Ltd.
  • Hunan Erkang Pharmaceutical Co., Ltd.
  • Hubei Renyue Pharmaceutical Co., Ltd.
  • Hubei Hendi Pharmaceutical Co., Ltd.
  • Hebei Changtian Pharmaceutical Co., Ltd.
  • Hebei Tiancheng Pharmaceutical Co., Ltd.
  • Hangzhou Minsheng Pharmaceutical Co., Ltd.
  • Harbin Pharmaceutical Group Pharmaceutical Factory
  • Sinopharm Guorui Pharmaceutical Co., Ltd.
  • Guilin Nanyao Co., Ltd.
  • Guangdong Xinfeng Pharmaceutical Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Isoniazid Tablets Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Isoniazid Tablets Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Isoniazid Tablets Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Isoniazid Tablets Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Isoniazid Tablets Market Dynamics
  1. 2.1 Isoniazid Tablets Industry Trends
  2. 2.2 Isoniazid Tablets Industry Drivers
  3. 2.3 Isoniazid Tablets Industry Opportunities and Challenges
  4. 2.4 Isoniazid Tablets Industry Restraints
3 Isoniazid Tablets Market by Manufacturers
  1. 3.1 Global Isoniazid Tablets Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Isoniazid Tablets Sales by Manufacturers (2021-2026)
  3. 3.3 Global Isoniazid Tablets Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Isoniazid Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Isoniazid Tablets Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Isoniazid Tablets Manufacturers, Product Type & Application
  7. 3.7 Global Isoniazid Tablets Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Isoniazid Tablets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Isoniazid Tablets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Isoniazid Tablets Tier 1, Tier 2, and Tier 3
4 Isoniazid Tablets Market by Type
  1. 4.1 Isoniazid Tablets Type Introduction
  2. 4.1.1 50mg
  3. 4.1.2 100mg
  4. 4.2 Global Isoniazid Tablets Sales by Type
  5. 4.2.1 Global Isoniazid Tablets Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Isoniazid Tablets Sales by Type (2021-2032)
  7. 4.2.3 Global Isoniazid Tablets Sales Market Share by Type (2021-2032)
  8. 4.3 Global Isoniazid Tablets Revenue by Type
  9. 4.3.1 Global Isoniazid Tablets Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Isoniazid Tablets Revenue by Type (2021-2032)
  11. 4.3.3 Global Isoniazid Tablets Revenue Market Share by Type (2021-2032)
5 Isoniazid Tablets Market by Application
  1. 5.1 Isoniazid Tablets Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Isoniazid Tablets Sales by Application
  6. 5.2.1 Global Isoniazid Tablets Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Isoniazid Tablets Sales by Application (2021-2032)
  8. 5.2.3 Global Isoniazid Tablets Sales Market Share by Application (2021-2032)
  9. 5.3 Global Isoniazid Tablets Revenue by Application
  10. 5.3.1 Global Isoniazid Tablets Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Isoniazid Tablets Revenue by Application (2021-2032)
  12. 5.3.3 Global Isoniazid Tablets Revenue Market Share by Application (2021-2032)
6 Global Isoniazid Tablets Sales by Region
  1. 6.1 Global Isoniazid Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Isoniazid Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Isoniazid Tablets Sales by Region (2021-2026)
  4. 6.2.2 Global Isoniazid Tablets Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Isoniazid Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Isoniazid Tablets Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Isoniazid Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Isoniazid Tablets Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Isoniazid Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Isoniazid Tablets Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Isoniazid Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Isoniazid Tablets Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Isoniazid Tablets Revenue by Region
  1. 7.1 Global Isoniazid Tablets Revenue by Region
  2. 7.1.1 Global Isoniazid Tablets Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Isoniazid Tablets Revenue by Region (2021-2026)
  4. 7.1.3 Global Isoniazid Tablets Revenue by Region (2027-2032)
  5. 7.1.4 Global Isoniazid Tablets Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Isoniazid Tablets Revenue (2021-2032)
  8. 7.2.2 North America Isoniazid Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Isoniazid Tablets Revenue (2021-2032)
  11. 7.3.2 Europe Isoniazid Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Isoniazid Tablets Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Isoniazid Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Isoniazid Tablets Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Isoniazid Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Yunpeng Pharmaceutical Group Co., Ltd.
  2. 8.1.1 Yunpeng Pharmaceutical Group Co., Ltd. Company Information
  3. 8.1.2 Yunpeng Pharmaceutical Group Co., Ltd. Business Overview
  4. 8.1.3 Yunpeng Pharmaceutical Group Co., Ltd. Isoniazid Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Yunpeng Pharmaceutical Group Co., Ltd. Isoniazid Tablets Product Portfolio
  6. 8.1.5 Yunpeng Pharmaceutical Group Co., Ltd. Recent Developments
  7. 8.2 Tonghua Baishan Pharmaceutical Co., Ltd.
  8. 8.2.1 Tonghua Baishan Pharmaceutical Co., Ltd. Company Information
  9. 8.2.2 Tonghua Baishan Pharmaceutical Co., Ltd. Business Overview
  10. 8.2.3 Tonghua Baishan Pharmaceutical Co., Ltd. Isoniazid Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Tonghua Baishan Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio
  12. 8.2.5 Tonghua Baishan Pharmaceutical Co., Ltd. Recent Developments
  13. 8.3 Tiansheng Pharmaceutical Group Co., Ltd.
  14. 8.3.1 Tiansheng Pharmaceutical Group Co., Ltd. Company Information
  15. 8.3.2 Tiansheng Pharmaceutical Group Co., Ltd. Business Overview
  16. 8.3.3 Tiansheng Pharmaceutical Group Co., Ltd. Isoniazid Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Tiansheng Pharmaceutical Group Co., Ltd. Isoniazid Tablets Product Portfolio
  18. 8.3.5 Tiansheng Pharmaceutical Group Co., Ltd. Recent Developments
  19. 8.4 Sichuan Deyuan Pharmaceutical Group Co., Ltd.
  20. 8.4.1 Sichuan Deyuan Pharmaceutical Group Co., Ltd. Company Information
  21. 8.4.2 Sichuan Deyuan Pharmaceutical Group Co., Ltd. Business Overview
  22. 8.4.3 Sichuan Deyuan Pharmaceutical Group Co., Ltd. Isoniazid Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Sichuan Deyuan Pharmaceutical Group Co., Ltd. Isoniazid Tablets Product Portfolio
  24. 8.4.5 Sichuan Deyuan Pharmaceutical Group Co., Ltd. Recent Developments
  25. 8.5 Sancai Shiqi Pharmaceutical Co., Ltd.
  26. 8.5.1 Sancai Shiqi Pharmaceutical Co., Ltd. Company Information
  27. 8.5.2 Sancai Shiqi Pharmaceutical Co., Ltd. Business Overview
  28. 8.5.3 Sancai Shiqi Pharmaceutical Co., Ltd. Isoniazid Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Sancai Shiqi Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio
  30. 8.5.5 Sancai Shiqi Pharmaceutical Co., Ltd. Recent Developments
  31. 8.6 Jiangxi Haiersi Pharmaceutical Co., Ltd.
  32. 8.6.1 Jiangxi Haiersi Pharmaceutical Co., Ltd. Company Information
  33. 8.6.2 Jiangxi Haiersi Pharmaceutical Co., Ltd. Business Overview
  34. 8.6.3 Jiangxi Haiersi Pharmaceutical Co., Ltd. Isoniazid Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Jiangxi Haiersi Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio
  36. 8.6.5 Jiangxi Haiersi Pharmaceutical Co., Ltd. Recent Developments
  37. 8.7 Jichuang Pharmaceutical Group Co., Ltd.
  38. 8.7.1 Jichuang Pharmaceutical Group Co., Ltd. Company Information
  39. 8.7.2 Jichuang Pharmaceutical Group Co., Ltd. Business Overview
  40. 8.7.3 Jichuang Pharmaceutical Group Co., Ltd. Isoniazid Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Jichuang Pharmaceutical Group Co., Ltd. Isoniazid Tablets Product Portfolio
  42. 8.7.5 Jichuang Pharmaceutical Group Co., Ltd. Recent Developments
  43. 8.8 Hunan Xinhui Pharmaceutical Co., Ltd.
  44. 8.8.1 Hunan Xinhui Pharmaceutical Co., Ltd. Company Information
  45. 8.8.2 Hunan Xinhui Pharmaceutical Co., Ltd. Business Overview
  46. 8.8.3 Hunan Xinhui Pharmaceutical Co., Ltd. Isoniazid Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Hunan Xinhui Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio
  48. 8.8.5 Hunan Xinhui Pharmaceutical Co., Ltd. Recent Developments
  49. 8.9 Hunan Shentaichun Pharmaceutical Co., Ltd.
  50. 8.9.1 Hunan Shentaichun Pharmaceutical Co., Ltd. Company Information
  51. 8.9.2 Hunan Shentaichun Pharmaceutical Co., Ltd. Business Overview
  52. 8.9.3 Hunan Shentaichun Pharmaceutical Co., Ltd. Isoniazid Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Hunan Shentaichun Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio
  54. 8.9.5 Hunan Shentaichun Pharmaceutical Co., Ltd. Recent Developments
  55. 8.10 Hunan Kangerjia Pharmaceutical Co., Ltd.
  56. 8.10.1 Hunan Kangerjia Pharmaceutical Co., Ltd. Company Information
  57. 8.10.2 Hunan Kangerjia Pharmaceutical Co., Ltd. Business Overview
  58. 8.10.3 Hunan Kangerjia Pharmaceutical Co., Ltd. Isoniazid Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Hunan Kangerjia Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio
  60. 8.10.5 Hunan Kangerjia Pharmaceutical Co., Ltd. Recent Developments
  61. 8.11 Hunan Hansen Pharmaceutical Co., Ltd.
  62. 8.11.1 Hunan Hansen Pharmaceutical Co., Ltd. Company Information
  63. 8.11.2 Hunan Hansen Pharmaceutical Co., Ltd. Business Overview
  64. 8.11.3 Hunan Hansen Pharmaceutical Co., Ltd. Isoniazid Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Hunan Hansen Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio
  66. 8.11.5 Hunan Hansen Pharmaceutical Co., Ltd. Recent Developments
  67. 8.12 Hunan Erkang Pharmaceutical Co., Ltd.
  68. 8.12.1 Hunan Erkang Pharmaceutical Co., Ltd. Company Information
  69. 8.12.2 Hunan Erkang Pharmaceutical Co., Ltd. Business Overview
  70. 8.12.3 Hunan Erkang Pharmaceutical Co., Ltd. Isoniazid Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Hunan Erkang Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio
  72. 8.12.5 Hunan Erkang Pharmaceutical Co., Ltd. Recent Developments
  73. 8.13 Hubei Renyue Pharmaceutical Co., Ltd.
  74. 8.13.1 Hubei Renyue Pharmaceutical Co., Ltd. Company Information
  75. 8.13.2 Hubei Renyue Pharmaceutical Co., Ltd. Business Overview
  76. 8.13.3 Hubei Renyue Pharmaceutical Co., Ltd. Isoniazid Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Hubei Renyue Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio
  78. 8.13.5 Hubei Renyue Pharmaceutical Co., Ltd. Recent Developments
  79. 8.14 Hubei Hendi Pharmaceutical Co., Ltd.
  80. 8.14.1 Hubei Hendi Pharmaceutical Co., Ltd. Company Information
  81. 8.14.2 Hubei Hendi Pharmaceutical Co., Ltd. Business Overview
  82. 8.14.3 Hubei Hendi Pharmaceutical Co., Ltd. Isoniazid Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Hubei Hendi Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio
  84. 8.14.5 Hubei Hendi Pharmaceutical Co., Ltd. Recent Developments
  85. 8.15 Hebei Changtian Pharmaceutical Co., Ltd.
  86. 8.15.1 Hebei Changtian Pharmaceutical Co., Ltd. Company Information
  87. 8.15.2 Hebei Changtian Pharmaceutical Co., Ltd. Business Overview
  88. 8.15.3 Hebei Changtian Pharmaceutical Co., Ltd. Isoniazid Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Hebei Changtian Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio
  90. 8.15.5 Hebei Changtian Pharmaceutical Co., Ltd. Recent Developments
  91. 8.16 Hebei Tiancheng Pharmaceutical Co., Ltd.
  92. 8.16.1 Hebei Tiancheng Pharmaceutical Co., Ltd. Company Information
  93. 8.16.2 Hebei Tiancheng Pharmaceutical Co., Ltd. Business Overview
  94. 8.16.3 Hebei Tiancheng Pharmaceutical Co., Ltd. Isoniazid Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Hebei Tiancheng Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio
  96. 8.16.5 Hebei Tiancheng Pharmaceutical Co., Ltd. Recent Developments
  97. 8.17 Hangzhou Minsheng Pharmaceutical Co., Ltd.
  98. 8.17.1 Hangzhou Minsheng Pharmaceutical Co., Ltd. Company Information
  99. 8.17.2 Hangzhou Minsheng Pharmaceutical Co., Ltd. Business Overview
  100. 8.17.3 Hangzhou Minsheng Pharmaceutical Co., Ltd. Isoniazid Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Hangzhou Minsheng Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio
  102. 8.17.5 Hangzhou Minsheng Pharmaceutical Co., Ltd. Recent Developments
  103. 8.18 Harbin Pharmaceutical Group Pharmaceutical Factory
  104. 8.18.1 Harbin Pharmaceutical Group Pharmaceutical Factory Company Information
  105. 8.18.2 Harbin Pharmaceutical Group Pharmaceutical Factory Business Overview
  106. 8.18.3 Harbin Pharmaceutical Group Pharmaceutical Factory Isoniazid Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Harbin Pharmaceutical Group Pharmaceutical Factory Isoniazid Tablets Product Portfolio
  108. 8.18.5 Harbin Pharmaceutical Group Pharmaceutical Factory Recent Developments
  109. 8.19 Sinopharm Guorui Pharmaceutical Co., Ltd.
  110. 8.19.1 Sinopharm Guorui Pharmaceutical Co., Ltd. Company Information
  111. 8.19.2 Sinopharm Guorui Pharmaceutical Co., Ltd. Business Overview
  112. 8.19.3 Sinopharm Guorui Pharmaceutical Co., Ltd. Isoniazid Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Sinopharm Guorui Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio
  114. 8.19.5 Sinopharm Guorui Pharmaceutical Co., Ltd. Recent Developments
  115. 8.20 Guilin Nanyao Co., Ltd.
  116. 8.20.1 Guilin Nanyao Co., Ltd. Company Information
  117. 8.20.2 Guilin Nanyao Co., Ltd. Business Overview
  118. 8.20.3 Guilin Nanyao Co., Ltd. Isoniazid Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Guilin Nanyao Co., Ltd. Isoniazid Tablets Product Portfolio
  120. 8.20.5 Guilin Nanyao Co., Ltd. Recent Developments
  121. 8.21 Guangdong Xinfeng Pharmaceutical Co., Ltd.
  122. 8.21.1 Guangdong Xinfeng Pharmaceutical Co., Ltd. Company Information
  123. 8.21.2 Guangdong Xinfeng Pharmaceutical Co., Ltd. Business Overview
  124. 8.21.3 Guangdong Xinfeng Pharmaceutical Co., Ltd. Isoniazid Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Guangdong Xinfeng Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio
  126. 8.21.5 Guangdong Xinfeng Pharmaceutical Co., Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Isoniazid Tablets Value Chain Analysis
  2. 9.1.1 Isoniazid Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Isoniazid Tablets Production Mode & Process
  6. 9.2 Isoniazid Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Isoniazid Tablets Distributors
  9. 9.2.3 Isoniazid Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst